Literature DB >> 24247142

In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.

Fabiola Fernández-Silva1, Javier Capilla, Emilio Mayayo, Deanna Sutton, Josep Guarro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24247142      PMCID： PMC3910885          DOI： 10.1128/AAC.02131-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  Successful treatment of Acremonium fungemia with voriconazole.

Authors:  D Mattei; N Mordini; C Lo Nigro; A Gallamini; M Osenda; F Pugno; C Viscoli
Journal:  Mycoses       Date:  2003-12       Impact factor: 4.377

2.  Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Guillermo Garcia-Effron; Laura Alcazar-Fuoli; Emilia Mellado; Maria J Buitrago; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.

Authors:  Enrique Calvo; F Javier Pastor; Valentina Salas; Emilio Mayayo; Josep Guarro
Journal:  Mycopathologia       Date:  2011-12-04       Impact factor: 2.574

4.  Acremonium kiliense: reappraisal of its clinical significance.

Authors:  Ziauddin Khan; Khaled Al-Obaid; Suhail Ahmad; Amal Abdel Ghani; Leena Joseph; Rachel Chandy
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

Review 5.  Acremonium species: new emerging fungal opportunists--in vitro antifungal susceptibilities and review.

Authors:  J Guarro; W Gams; I Pujol; J Gené
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

6.  Genetic diversity among clinical isolates of Acremonium strictum determined during an investigation of a fatal mycosis.

Authors:  Thomas J Novicki; Karen LaFe; Lynda Bui; Uyen Bui; Robert Geise; Kieren Marr; Brad T Cookson
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

7.  Spectrum of clinically relevant Acremonium species in the United States.

Authors:  H Perdomo; D A Sutton; D García; A W Fothergill; J Cano; J Gené; R C Summerbell; M G Rinaldi; J Guarro
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

8.  Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium.

Authors:  R C Summerbell; C Gueidan; H-J Schroers; G S de Hoog; M Starink; Y Arocha Rosete; J Guarro; J A Scott
Journal:  Stud Mycol       Date:  2011       Impact factor: 16.097

9.  In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.

Authors:  Itamar Shalit; Yona Shadkchan; Zmira Samra; Nir Osherov
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

10.  In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus.

Authors:  Eric Dannaoui; Olivier Lortholary; Françoise Dromer
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191
View more
  1 in total

1.  Cork Oak Endophytic Fungi as Potential Biocontrol Agents against Biscogniauxia mediterranea and Diplodia corticola.

Authors:  Daniela Costa; Rui M Tavares; Paula Baptista; Teresa Lino-Neto
Journal:  J Fungi (Basel)       Date:  2020-11-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.